Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma
- PMID: 24348785
- PMCID: PMC3861183
- DOI: 10.3892/etm.2013.1375
Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma
Abstract
Oxidative stress is significant in numerous types of cancer. Tobacco smoke, an important risk factor for oral squamous cell carcinoma (OSCC), is able to generate reactive oxygen species (ROS) and cause oxidative DNA damage. Superoxide dismutase (SOD) is an endogenous antioxidant enzyme that is critical in limiting the oxidative burden effectively. The purpose of this study was to investigate the effects of the mitochondrial SOD2 and Cu/Zn enzyme SOD1 gene polymorphisms on the susceptibility to and clinicopathological characteristics of OSCC, as well as the synergistic effect between these gene polymorphisms and the well-known risk factor of tobacco consumption. Patients with clinically diagnosed OSCC (n=362) and healthy normal individuals (n=358) were investigated for four single nucleotide polymorphisms (SNPs; rs4880, rs5746136, rs1804450 and rs11556620) by polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing methods. Following adjustment for other confounders, no significant difference was observed in the rs5746136 SOD2 SNPs between the patients and controls. However, the incidence of the CT genotype of SOD2 SNP rs4880 was higher in the patients than in normal subjects in the additive model [CT vs. TT; P=0.045; adjusted odds ratio (AOR)=1.484; 95% confidence interval (CI), 1.009-2.182] and in the dominant model (CT/CC vs. TT; P=0.022; AOR=1.559; 95% CI, 1.067-2.278). For those who smoked, the incidence of the CT genotype of rs4880 increased markedly in the patients compared with the controls in the additive model (CT vs. TT; P=0.003; AOR=2.325; 95% CI, 1.330-4.064) and in the dominant model (CT/CC vs. TT; P=0.001; AOR=2.448; 95% CI, 1.417-4.230). For SOD1, polymorphisms at rs1804450 and rs11556620 were not present in any of the OSCC or control subjects. The results suggest that SOD2 rs4880 may be involved in the tumorigenesis of OSCC and may be useful as a genetic susceptibility marker for OSCC.
Keywords: gene polymorphisms; mitochondrial superoxide dismutase 2; oral squamous cell carcinoma; superoxide dismutase 1.
Similar articles
-
Superoxide Dismutase (rs2070424, rs4880, rs2536512) and Catalase (rs794316, rs1001179) SNPs and their Association with Breast Cancer Risk: Findings from a Hospital Based Case-Control Study.Asian Pac J Cancer Prev. 2024 Jan 1;25(1):175-184. doi: 10.31557/APJCP.2024.25.1.175. Asian Pac J Cancer Prev. 2024. PMID: 38285782 Free PMC article.
-
Association of SOD2 rs2758339, rs5746136 and rs2842980 polymorphisms with increased risk of breast cancer: a haplotype-based case-control study.Genes Genomics. 2023 Sep;45(9):1165-1178. doi: 10.1007/s13258-023-01399-1. Epub 2023 May 30. Genes Genomics. 2023. PMID: 37253908
-
SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk.Curr Issues Mol Biol. 2022 Oct 26;44(11):5221-5233. doi: 10.3390/cimb44110355. Curr Issues Mol Biol. 2022. PMID: 36354667 Free PMC article.
-
Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.Free Radic Biol Med. 2013 Dec;65:1110-1125. doi: 10.1016/j.freeradbiomed.2013.08.189. Epub 2013 Sep 12. Free Radic Biol Med. 2013. PMID: 24036105
-
The association between MTHFR gene polymorphisms (C677T, A1298C) and oral squamous cell carcinoma: A systematic review and meta-analysis.PLoS One. 2018 Aug 24;13(8):e0202959. doi: 10.1371/journal.pone.0202959. eCollection 2018. PLoS One. 2018. PMID: 30142181 Free PMC article.
Cited by
-
Association between MnSOD Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls.Dis Markers. 2018 Sep 2;2018:3061974. doi: 10.1155/2018/3061974. eCollection 2018. Dis Markers. 2018. PMID: 30245752 Free PMC article.
-
Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136.Pharmacogenomics. 2025 Feb-Mar;26(3-4):95-105. doi: 10.1080/14622416.2025.2490467. Epub 2025 Apr 16. Pharmacogenomics. 2025. PMID: 40235344
-
Transcriptome analysis and prognosis of ALDH isoforms in human cancer.Sci Rep. 2018 Feb 9;8(1):2713. doi: 10.1038/s41598-018-21123-4. Sci Rep. 2018. PMID: 29426835 Free PMC article.
-
Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma.Oncol Lett. 2015 Oct;10(4):2432-2438. doi: 10.3892/ol.2015.3598. Epub 2015 Aug 12. Oncol Lett. 2015. PMID: 26622865 Free PMC article.
-
Caspase-8 polymorphisms and risk of oral squamous cell carcinoma.Exp Ther Med. 2015 Dec;10(6):2267-2276. doi: 10.3892/etm.2015.2832. Epub 2015 Oct 26. Exp Ther Med. 2015. PMID: 26668627 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma: Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg. 2008;46:1–5. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243–250. - PubMed
-
- Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779–4786. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous